OpenAlex
PricingAboutJobs
Log inGet started
Work

A 24-week Randomized, Controlled Trial of Memantine in Patients With Moderate-to-severe Alzheimer Disease

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Alzheimer Disease & Associated Disorders
DOI: 10.1097/wad.0b013e318065c495
Authors: Christopher H. van Dyck, Pierre N. Tariot, Barnett Meyers, E. Malca Resnick
Institutions: Yale University, Banner Alzheimer’s Institute, Weill Cornell Medicine, Forest Laboratories (United States)
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: memantine, Alzheimer's disease, NMDA receptor antagonists, monotherapy, Severe Impairment Battery, activities of daily living, CIBIC-Plus, treatment efficacy, drug safety, adverse events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2058112065
FWCI: 8.109
Cites: 17
Cited by: 195
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms